|
|
|
|
|
|
|
|
|
|
Diluted chemotherapy drugs affect 1200 patients in Canada : The Lancet Oncology
The Lancet Oncology, Early Online Publication, 12 April 2013
doi:10.1016/S1470-2045(13)70137-2
Cite or Link Using DOI
Cite or Link Using DOI
"Drug
supplier Mezentco (Hamilton, ON, Canada) faces a class action lawsuit
for the accidental dilution of two chemotherapy drugs supplied to five
hospitals since February, 2012. The products affected are
cyclophosphamide and gemcitabine, which are used to treat breast cancer,
lung cancer, lymphoma, and leukaemia. After the issue was discovered at
the Windsor Regional Hospital (Windsor, ON), an investigation revealed
that the supplier had been improperly mixing the drugs, resulting in a
3—20% dil ..."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.